Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies.
Beard
Michael R
MR
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D016896:Treatment Outcome; D019892:eIF-2 Kinase / Q000235:genetics / Q000378:metabolism
D000998:Antiviral Agents; D016898:Interferon-alpha; D019892:eIF-2 Kinase